{"id":"https://openalex.org/A5007970285","orcid":"https://orcid.org/0000-0003-3301-1809","observed_orcids":["https://orcid.org/0000-0003-3301-1809"],"display_name":"\u0396\u03ae\u03bd\u03c9\u03bd \u0396\u03ae\u03bd\u03c9\u03bd\u03bf\u03c2","raw_author_names":["Z. Zenonos","Zenon A Zenonos","Zenon A. Zenonos","Zenon Zenonos","\u0396\u03ae\u03bd\u03c9\u03bd \u0396\u03ae\u03bd\u03c9\u03bd\u03bf\u03c2"],"full_name":"Zenon A Zenonos","works_count":35,"cited_by_count":601,"summary_stats":{"2yr_mean_citedness":0.8947368421052632,"h_index":10,"i10_index":10},"ids":{"openalex":"https://openalex.org/A5007970285","orcid":"https://orcid.org/0000-0003-3301-1809","observed_orcids":["https://orcid.org/0000-0003-3301-1809"]},"affiliations":[{"institution":{"id":"https://openalex.org/I105036370","ror":"https://ror.org/04r9x1a08","display_name":"AstraZeneca (United Kingdom)","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]},"years":[2026,2025,2024,2023,2022,2021]},{"institution":{"id":"https://openalex.org/I2802476451","ror":"https://ror.org/05cy4wa09","display_name":"Wellcome Sanger Institute","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2802476451","https://openalex.org/I87048295"]},"years":[2024,2022,2021,2019,2018,2015,2014,2011]}],"last_known_institutions":[{"id":"https://openalex.org/I105036370","ror":"https://ror.org/04r9x1a08","display_name":"AstraZeneca (United Kingdom)","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"topics":[{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","count":17,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","count":14,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12477","display_name":"Toxin Mechanisms and Immunotoxins","count":14,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10091","display_name":"Malaria Research and Control","count":9,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","count":5,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"topic_share":[{"id":"https://openalex.org/T12477","display_name":"Toxin Mechanisms and Immunotoxins","value":0.0002426,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","value":0.0001812,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","value":5.06e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","value":4.07e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13127","display_name":"Biotin and Related Studies","value":3.94e-05,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"x_concepts":[{"id":"86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","score":0.8190708160400391},{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.5882999897003174},{"id":"41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","score":0.5445407629013062},{"id":"154945302","wikidata":"https://www.wikidata.org/wiki/Q11660","display_name":"Artificial intelligence","score":0.37290000915527344},{"id":"2776401178","wikidata":"https://www.wikidata.org/wiki/Q12050496","display_name":"Feature (linguistics)","score":0.36340001225471497}],"counts_by_year":[{"year":2009,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":2011,"works_count":1,"oa_works_count":1,"cited_by_count":0},{"year":2012,"works_count":0,"oa_works_count":0,"cited_by_count":32},{"year":2013,"works_count":0,"oa_works_count":0,"cited_by_count":41},{"year":2014,"works_count":1,"oa_works_count":1,"cited_by_count":33},{"year":2015,"works_count":2,"oa_works_count":2,"cited_by_count":33},{"year":2016,"works_count":0,"oa_works_count":0,"cited_by_count":33},{"year":2017,"works_count":0,"oa_works_count":0,"cited_by_count":21},{"year":2018,"works_count":1,"oa_works_count":1,"cited_by_count":28},{"year":2019,"works_count":2,"oa_works_count":2,"cited_by_count":36},{"year":2020,"works_count":0,"oa_works_count":0,"cited_by_count":50},{"year":2021,"works_count":2,"oa_works_count":1,"cited_by_count":55},{"year":2022,"works_count":1,"oa_works_count":1,"cited_by_count":39},{"year":2023,"works_count":5,"oa_works_count":4,"cited_by_count":40},{"year":2024,"works_count":1,"oa_works_count":1,"cited_by_count":71},{"year":2025,"works_count":17,"oa_works_count":17,"cited_by_count":42},{"year":2026,"works_count":1,"oa_works_count":1,"cited_by_count":46}],"display_name_alternatives":["Z. Zenonos","Zenon A Zenonos","Zenon A. Zenonos","Zenon Zenonos","\u0396\u03ae\u03bd\u03c9\u03bd \u0396\u03ae\u03bd\u03c9\u03bd\u03bf\u03c2"],"block_key":"z zenonos","works_api_url":"https://api.openalex.org/works?filter=author.id:A5007970285","updated_date":"2026-11-08T12:57:04","created_date":"2016-06-24T00:00:00"}